Share Email Print

Proceedings Paper

Detection of breast positive surgical margins with fluorescence-guided microscopy imaging (Conference Presentation)
Author(s): Nicusor V. Iftimia; Dorin Preda; Jesung Park; Mitchell Antalek

Paper Abstract

We present a novel technology based on a high sensitivity/specificity cancer targeting agent and of a novel fluorescence-guided microscopy (FGM) scheme for intraoperative assessment of surgical margins in breast cancer patients. Cancer cells are targeted using an optically silent peptide substrate coupled to a near infrared (NIR) fluorochrome that is cleaved by highly mediated breast cancer enzymes, like urokinase-type plasminogen activator (uPA), to become highly fluorescent when excited by a NIR laser beam. A FGM instrument is used to localize cancer-suspect areas on the lumpectomy specimen and visualize tissue morphology at the sub-cellular scale, such that a trained pathologist can read these images in real-time and confirm or rule-out cancer presence. The proposed technology will enable efficient assessment of surgical specimens during surgery, when it is mostly needed, and therefore help the clinician to determine if additional tissue excision is needed or not. The preliminary testing of this technology on breast surgical specimens will be discussed.

Paper Details

Date Published: 26 April 2016
PDF: 1 pages
Proc. SPIE 9696, Molecular-Guided Surgery: Molecules, Devices, and Applications II, 96960S (26 April 2016); doi: 10.1117/12.2213887
Show Author Affiliations
Nicusor V. Iftimia, Physical Sciences Inc. (United States)
Dorin Preda, Physical Sciences Inc. (United States)
Jesung Park, Physical Sciences Inc. (United States)
Mitchell Antalek, Physical Sciences Inc. (United States)

Published in SPIE Proceedings Vol. 9696:
Molecular-Guided Surgery: Molecules, Devices, and Applications II
Brian W. Pogue; Sylvain Gioux, Editor(s)

© SPIE. Terms of Use
Back to Top